Real Estate admin  

AstraZeneca: No approval applied for in the USA yet

Due to delays in the test phase last fall, AstraZeneca has not yet submitted an application for approval in the USA.


SN / AFP

Due to neurological side effects in two volunteers, the company had to suspend its tests for almost seven weeks in the fall. As a result, the AstraZeneca vaccine slipped from first place in the race for approval in the USA.

The FDA is expected to soon receive an application from the pharmaceutical company that has completed the third phase of its testing of the vaccine. Experts like Daniel Salmon, director at the “Institute for Vaccine Safety” at the renowned …

Select the offer and read on

Read all articles.

  • Exclusive SN Plus content from renowned SN editors
  • The digital newspaper as an e-paper in the SN app every day
  • Automatically ends

The first 3 months for only 0.99 euros per month.

Are you already a digital subscriber?

Your 30-day trial has expired

The first 3 months for only 0.99 euros per month.

  • Exclusive SN Plus content from renowned SN editors
  • The digital newspaper as an e-paper in the SN app every day
  • Cancel anytime after 3 months

* Monthly price after 3 months: from € 4.50

Accessed on March 17, 2021 at 8:30 am on https://www.sn.at/politik/weltpolitik/astrazeneca-noch-keine-zulassung-in-den-usa-beantracht-101184100

Leave A Comment

1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1